Banner

Cancer Clinical Decision Tools Global Market Report 2023 – By Type (Risk Assessment Tool(RAT), Qcancer), By End-User (Hospital, Clinics) – Market Size, Trends, And Market Forecast 2023-2032

Starting Price : $5000.00 | Pages : 250 | Published : January 2023 | SKU CODE : h1193 | Delivery Time: 2-3 business days | Format :


Cancer clinical decision tools refer to the tools that are developed to help medical practitioners identify suspected cancer signs and symptoms and treat patients effectively. These tools aid in clinical decision-making by assisting GPs in deciding whether to refer or seek additional diagnostic testing in patients suspected of having cancer.

The main types of cancer clinical decision tools are risk assessment tools (RAT) and Qcancer. By examining a combination of risk factors, including genetic, environmental, and behavioural risk factors, risk assessment tools make it easier to translate these risk models into estimates of an individual’s likelihood of acquiring certain malignancies. The different sectors include hospitals and clinics.

The cancer clinical decision tools market research report is one of a series of new reports from The Business Research Company that provides cancer clinical decision tools market statistics, including cancer clinical decision tools industry global market size, regional shares, competitors with a cancer clinical decision tools market share, detailed cancer clinical decision tools market segments, market trends and opportunities, and any further data you may need to thrive in the cancer clinical decision tools industry. This cancer clinical decision tools market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The global cancer clinical decision market grew from $0.4 billion in 2022 to $0.45 billion in 2023 at a compound annual growth rate (CAGR) of 13.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The cancer clinical decision market is expected to grow from $0.65 billion in 2027 at a CAGR of 9.9%.

The rise in the number of cancer cases across the globe is likely to contribute to the growth of the cancer clinical decision-making tools market. For instance, in January 2022, according to the American Cancer Society, there will likely be 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the US, or roughly 1,670 fatalities every day. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43 percent of all new cancer cases. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43 percent of all new cancer cases. Therefore, the rise in cancer incidence rates across the globe will increase the demand for cancer clinical decision tools to make treatment decisions faster, thereby contributing to the market's growth.

The breach of patient data and privacy is a major challenge in the market for cancer clinical decision tools. Hackers can get access to data centres through healthcare employees’ emails, leading to a breach of patients' privacy. For instance, in October 2021, according to Fortune, a US-based publishing company specialising in the publication of books, articles, and magazines, the total number of global data breach cases was 1291 in 2021, up from 1108 in 2020. Phishing and ransomware are the major tools used by cybercriminals, and the total number of data breaches is expected to increase to 17% in 2021. The risk of a loss of data and the privacy of patients harms the growth of the market for cancer clinical decision tools.

In March 2021, NeoGenomics Laboratories, Inc., a US-based company that provides clinical laboratories, pharmaceutical services, and information services and focuses on cancer genetics diagnostic testing, acquired Trapelo Health, LLC., for an amount of $65 million. Through this acquisition, NeoGenomics would be able to apply precision oncology. In order to help doctors, labs, and payers choose diagnostics and treatments, enhance clinical trial matching, expedite workflow, and enable real-time alignment with the most recent clinical data, the firm offers a first-of-its-kind, interoperable, decision-support platform. The platform makes it easier for patients to access high-quality, medically acceptable therapy alternatives. This acquisition allows NeoGenomics to utilise a single technological platform developed by Trapelo Health that enables real-time, evidence-based decision assistance, treatment selection, and reimbursement assurance for oncologists, giving patients the best chance to cure cancer. Trapelo Health, LLC., is a healthcare technology company specialising in a decision-support platform, order management, and results reporting solution for molecular testing for cancer.

Major players in the cancer clinical decision tools market are McKesson Corporation, Medical Information Technology Inc., Philips Healthcare, Siemens Healthcare, Elsevier B.V., Macmillan, and National Decision Support Company.

North America was the largest region in the cancer clinical decision tools market in 2022.

The regions covered in the global cancer clinical decision tools market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the cancer clinical decision tools market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The market for cancer clinical decision tools consists of sales of risk assessment tools, Q-Cancer tools, and MacMillan’s cancer decision tool. Values in this market are "factory gate values," that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resale, either further along the supply chain or as part of other products.

The global cancer clinical decision tools market is segmented -

1) By Type: Risk Assessment Tool (RAT), Qcancer

2) By End-User: Hospital, Clinics

    Table Of Contents

    1. Executive Summary

    2. Cancer Clinical Decision Tools Market Characteristics

    3. Cancer Clinical Decision Tools Market Trends And Strategies

    4. Cancer Clinical Decision Tools Market – Macro Economic Scenario

    4.1 COVID-19 Impact On Cancer Clinical Decision Tools Market

    4.2 Ukraine-Russia War Impact On Cancer Clinical Decision Tools Market

    4.3 Impact Of High Inflation On Cancer Clinical Decision Tools Market

    5. Cancer Clinical Decision Tools Market Size And Growth

    5.1. Global Cancer Clinical Decision Tools Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Cancer Clinical Decision Tools Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Cancer Clinical Decision Tools Market Segmentation

    6.1. Global Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Risk Assessment Tool(RAT)

    Qcancer

    6.2. Global Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospital

    Clinics

    7. Cancer Clinical Decision Tools Market Regional And Country Analysis

    7.1. Global Cancer Clinical Decision Tools Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Cancer Clinical Decision Tools Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Cancer Clinical Decision Tools Market

    8.1. Asia-Pacific Cancer Clinical Decision Tools Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Cancer Clinical Decision Tools Market

    9.1. China Cancer Clinical Decision Tools Market Overview

    9.2. China Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Cancer Clinical Decision Tools Market

    10.1. India Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Cancer Clinical Decision Tools Market

    11.1. Japan Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Cancer Clinical Decision Tools Market

    12.1. Australia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Cancer Clinical Decision Tools Market

    13.1. Indonesia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Cancer Clinical Decision Tools Market

    14.1. South Korea Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Cancer Clinical Decision Tools Market

    15.1. Western Europe Cancer Clinical Decision Tools Market Overview

    15.2. Western Europe Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Cancer Clinical Decision Tools Market

    16.1. UK Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Cancer Clinical Decision Tools Market

    17.1. Germany Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Cancer Clinical Decision Tools Market

    18.4. France Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Cancer Clinical Decision Tools Market

    19.1. Eastern Europe Cancer Clinical Decision Tools Market Overview

    19.2. Eastern Europe Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Cancer Clinical Decision Tools Market

    20.1. Russia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Cancer Clinical Decision Tools Market

    21.1. North America Cancer Clinical Decision Tools Market Overview

    21.2. North America Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Cancer Clinical Decision Tools Market

    22.1. USA Cancer Clinical Decision Tools Market Overview

    22.2. USA Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Cancer Clinical Decision Tools Market

    23.1. South America Cancer Clinical Decision Tools Market Overview

    23.2. South America Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Cancer Clinical Decision Tools Market

    24.1. Brazil Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Cancer Clinical Decision Tools Market

    25.1. Middle East Cancer Clinical Decision Tools Market Overview

    25.2. Middle East Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Cancer Clinical Decision Tools Market

    26.1. Africa Cancer Clinical Decision Tools Market Overview

    26.2. Africa Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Cancer Clinical Decision Tools Market Competitive Landscape And Company Profiles

    27.1. Cancer Clinical Decision Tools Market Competitive Landscape

    27.2. Cancer Clinical Decision Tools Market Company Profiles

    27.2.1. McKesson Corporation

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Medical Information Technology Inc.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Philips Healthcare

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Elsevier B.V.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Siemens Healthineers

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Cancer Clinical Decision Tools Market

    29. Cancer Clinical Decision Tools Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Cancer Clinical Decision Tools Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Cancer Clinical Decision Tools Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Asia-Pacific, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: China, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: India, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: Japan, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Australia, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Indonesia, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: South Korea, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: Western Europe, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: UK, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: Germany, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: France, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: Eastern Europe, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Russia, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: North America, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: USA, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: South America, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: Brazil, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Middle East, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Africa, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: McKesson Corporation Financial Performance
  • Table 46: Medical Information Technology Inc. Financial Performance
  • Table 47: Philips Healthcare Financial Performance
  • Table 48: Elsevier B.V. Financial Performance
  • Table 49: Siemens Healthineers Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Cancer Clinical Decision Tools Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Cancer Clinical Decision Tools Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Asia-Pacific, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: China, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: India, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: Japan, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Australia, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Indonesia, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: South Korea, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: Western Europe, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: UK, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: Germany, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: France, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: Eastern Europe, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Russia, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: North America, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: USA, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: South America, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: Brazil, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Middle East, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Africa, Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: McKesson Corporation Financial Performance
  • Figure 46: Medical Information Technology Inc. Financial Performance
  • Figure 47: Philips Healthcare Financial Performance
  • Figure 48: Elsevier B.V. Financial Performance
  • Figure 49: Siemens Healthineers Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report